Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure (Q47702359)

4 February 2018

title

Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure (English)

1 reference

4 February 2018

1 reference

2

Geir Christensen

1 reference

4 February 2018

3

Torbjørn Omland

1 reference

4 February 2018

4

Helge Røsjø

1 reference

4 February 2018

Anett H Ottesen

1

1 reference

4 February 2018

publication date

3 October 2017

1 reference

4 February 2018

Current heart failure reports

published in

1 reference

4 February 2018

volume

14

1 reference

4 February 2018

issue

6

1 reference

4 February 2018

page(s)

478-488

1 reference

4 February 2018

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib

cites work

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

In search of new therapeutic targets and strategies for heart failure: recent advances in basic science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

The Extended Granin Family: Structure, Function, and Biomedical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

The granin (chromogranin/secretogranin) family

21 January 2018

2 references

https://api.crossref.org/works/10.1007/S11897-017-0360-X

21 January 2018

12 December 2020

Secretogranin II; a protein increased in the myocardium and circulation in heart failure with cardioprotective properties

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Cathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Comparative studies on the soluble protein fractions of bovine, equine, porcine and ovine adrenal chromaffin granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

The chromogranin-secretogranin family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

The chromogranins A and B: the first 25 years and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga364–384)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

The major tyrosine-sulfated protein of the bovine anterior pituitary is a secretory protein present in gonadotrophs, thyrotrophs, mammotrophs, and corticotrophs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Chromogranins A, B, and C: widespread constituents of secretory vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Regulation of exocytotic protein expression and Ca2 -dependent peptide secretion in astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Release of secretoneurin and noradrenaline from hypothalamic slices and its differential inhibition by calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Neuroendocrine cell type-specific and inducible expression of chromogranin/secretogranin genes: crucial promoter motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Secretory granules in inositol 1,4,5-trisphosphate-dependent Ca2 signaling in the cytoplasm of neuroendocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Inositol 1,4,5-Trisphosphate Receptor in Chromaffin Secretory Granules and Its Relation to Chromogranins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Enrichment of the inositol 1,4,5-trisphosphate receptor/Ca2 channels in secretory granules and essential roles of chromogranins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

The Neuropeptide Catestatin Acts As a Novel Angiogenic Cytokine via a Basic Fibroblast Growth Factor–Dependent Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Monocyte migration: a novel effect and signaling pathways of catestatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Secretoneurin is a novel prognostic cardiovascular biomarker associated with cardiomyocyte calcium handling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

CaMKII in myocardial hypertrophy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Chromogranin B in heart failure: a putative cardiac biomarker expressed in the failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Association between plasma chromogranin A concentration and long-term mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Prognostic value of circulating chromogranin A levels in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Prognostic value of chromogranin A in severe sepsis: data from the FINNSEPSIS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Prognostic value of chromogranin A at admission in critically ill patients: a cohort study in a medical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Making sense of chromogranin A in heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Circulating chromogranin B levels in patients with acute respiratory failure: data from the FINNALI Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Prognostic Value of Secretoneurin in Critically Ill Patients With Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Prognostic Value of Secretoneurin in Patients with Acute Respiratory Failure: Data from the FINNALI Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Secretoneurin as a marker for hypoxic brain injury after cardiopulmonary resuscitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Effect of short- and long-term physical activities on circulating granin protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Chromogranin A from bovine adrenal medulla: molecular characterization of glycosylations, phosphorylations, and sequence heterogeneities by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Full-length human chromogranin-A cardioactivity: myocardial, coronary, and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus Cardiac Examination 2 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Effect of sialylated O-glycans in pro-brain natriuretic peptide stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Chromogranin a and the autonomic system: decomposition of heart rate variability and rescue by its catestatin fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Catestatin improves post-ischemic left ventricular function and decreases ischemia/reperfusion injury in heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia/reperfusion by stimulating PI3K-Akt-GSK3β pathway and preserving mitochondrial membrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Chromogranin-A: a multifaceted cardiovascular role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Vasostatins exert negative inotropism in the working heart of the frog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

The novel chromogranin A-derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β-adrenergic-like inotropes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Antiarrhythmic effects of vasostatin-1 in a canine model of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Overexpression of Vasostatin‐1 Protects Hypoxia/Reoxygenation Injuries in Cardiomyocytes Independent of Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Identification of the Vasoconstriction-Inhibiting Factor (VIF), a Potent Endogenous Cofactor of Angiotensin II Acting on the Angiotensin II Type 2 Receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Secretoneurin gene therapy improves blood flow in an ischemia model in type 1 diabetic mice by enhancing therapeutic neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-017-0360-X

Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction

21 January 2018

1 reference

12 December 2020

Secretogranin II: relative amounts and processing to secretoneurin in various rat tissues.

1 reference

12 December 2020

The catecholamine release-inhibitory peptide catestatin (chromogranin A344-363) modulates myocardial function in fish

1 reference

12 December 2020

Coupling of the inositol 1,4,5-trisphosphate receptor and chromogranins A and B in secretory granules

1 reference

12 December 2020

Elevated serum chromogranin A concentrations in small-cell lung carcinoma

1 reference

12 December 2020

Catestatin is useful in detecting patients with stage B heart failure

1 reference

12 December 2020

Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure

1 reference

12 December 2020

Chromogranins A and B are co-localized with atrial natriuretic peptides in secretory granules of rat heart

1 reference

12 December 2020

Secretion of chromogranin A by peptide-producing endocrine neoplasms

1 reference

12 December 2020

The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels

1 reference

12 December 2020

Use of neuroendocrine serum markers in the follow-up of patients with cancer of the prostate

1 reference

12 December 2020

Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease

1 reference

12 December 2020

The release of chromogranin A and B like activity from human lung cancer cell lines. A potential marker for a subset of small cell lung cancer

1 reference

12 December 2020

10.1007/S11897-017-0360-X

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018